Whilst both may benefit from an ageing population and there is some share of staff, I can't imagine a scenario where they are partnered in any way, if that is what is being alluded to (may not be, apologies). Without knowing much about EMV, it sounds like they are involved in the biotech/diagnosis side of things. AGN is a pure drug play.
Anything under a cheeky dollar this is a steal, page-10
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.5¢ |
Change
-0.005(0.58%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 83.0¢ | $33.74K | 39.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23732 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.5¢ | 3548 | 1 |
View Market Depth
| Last trade - 10.56am 23/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |